Work

Single‐ and Multiple‐Dose Safety, Tolerability, and Pharmacokinetic Profiles of ASP8062: Results From 2 Phase 1 Studies

Year: 2020

Type: article

Study design: Clinical Trial

Source: Clinical Pharmacology in Drug Development

DOI: 10.1002/cpdd.766

Authors: Mark Walzer, Gerard J. Marek, Ruishan Wu, Masanori Nagata, David Han

Institutions: Astellas Pharma (United States), Astellas Pharma (Japan)

Language: English

Topic: Neuroscience and Neuropharmacology Research

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Astellas Pharma US

OpenAlex ID: W2998813706

FWCI: 1.25

Cites: 28

Cited by: 19

Related to: 10